Betta Pharmaceuticals saw the highest growth of 1.32% in patent filings in May and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.29% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Betta Pharmaceuticals’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Betta Pharmaceuticals has been focused on protecting inventions in European Patent Office(EPO) with eight publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 45% of filings. The European Patent Office(EPO), Israel(IL), Australia(AU), and South Korea(KR) patent Office are among the top ten patent offices where Betta Pharmaceuticals is filings its patents. Among the top granted patent authorities, Betta Pharmaceuticals has 67% of its grants in Israel(IL) and 33% in Australia(AU).
Roche and Johnson & Johnson could be the strongest competitors for Betta Pharmaceuticals
Patents related to rare diseases lead Betta Pharmaceuticals's portfolio
Betta Pharmaceuticals has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Petrochemicals related patents lead Betta Pharmaceuticals portfolio followed by breast cancer, and bladder carcinoma
Betta Pharmaceuticals has highest number of patents in petrochemicals followed by breast cancer, bladder carcinoma, nonmelanomatous skin cancer, and melanoma.
For comprehensive analysis of Betta Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
